4-168878164-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The ENST00000507735.6(PALLD):​c.273G>C​(p.Pro91Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P91P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 30)
Exomes 𝑓: 0.028 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PALLD
ENST00000507735.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.600

Publications

1 publications found
Variant links:
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 4-168878164-G-C is Benign according to our data. Variant chr4-168878164-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 215805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.6 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PALLDNM_001166108.2 linkc.1965-12758G>C intron_variant Intron 10 of 21 ENST00000505667.6 NP_001159580.1 Q8WX93-9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PALLDENST00000505667.6 linkc.1965-12758G>C intron_variant Intron 10 of 21 1 NM_001166108.2 ENSP00000425556.1 Q8WX93-9

Frequencies

GnomAD3 genomes
AF:
0.00156
AC:
161
AN:
102898
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00299
Gnomad AMI
AF:
0.00179
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.000379
Gnomad EAS
AF:
0.00175
Gnomad SAS
AF:
0.00171
Gnomad FIN
AF:
0.00415
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000644
Gnomad OTH
AF:
0.00147
GnomAD2 exomes
AF:
0.0208
AC:
1188
AN:
57246
AF XY:
0.0161
show subpopulations
Gnomad AFR exome
AF:
0.112
Gnomad AMR exome
AF:
0.0803
Gnomad ASJ exome
AF:
0.0196
Gnomad EAS exome
AF:
0.0283
Gnomad FIN exome
AF:
0.0132
Gnomad NFE exome
AF:
0.0110
Gnomad OTH exome
AF:
0.0211
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0280
AC:
10284
AN:
367294
Hom.:
0
Cov.:
25
AF XY:
0.0270
AC XY:
4998
AN XY:
185078
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0451
AC:
323
AN:
7168
American (AMR)
AF:
0.131
AC:
1123
AN:
8602
Ashkenazi Jewish (ASJ)
AF:
0.0401
AC:
288
AN:
7176
East Asian (EAS)
AF:
0.0274
AC:
88
AN:
3216
South Asian (SAS)
AF:
0.0277
AC:
895
AN:
32364
European-Finnish (FIN)
AF:
0.0486
AC:
265
AN:
5454
Middle Eastern (MID)
AF:
0.0372
AC:
39
AN:
1048
European-Non Finnish (NFE)
AF:
0.0235
AC:
6769
AN:
288510
Other (OTH)
AF:
0.0359
AC:
494
AN:
13756
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.259
Heterozygous variant carriers
0
1281
2561
3842
5122
6403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00155
AC:
160
AN:
102930
Hom.:
0
Cov.:
30
AF XY:
0.00139
AC XY:
70
AN XY:
50308
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00299
AC:
78
AN:
26100
American (AMR)
AF:
0.00124
AC:
13
AN:
10460
Ashkenazi Jewish (ASJ)
AF:
0.000379
AC:
1
AN:
2636
East Asian (EAS)
AF:
0.00175
AC:
6
AN:
3420
South Asian (SAS)
AF:
0.00171
AC:
5
AN:
2918
European-Finnish (FIN)
AF:
0.00415
AC:
23
AN:
5536
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
232
European-Non Finnish (NFE)
AF:
0.000624
AC:
31
AN:
49696
Other (OTH)
AF:
0.00146
AC:
2
AN:
1372
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.254
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0102
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 29, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Pancreatic adenocarcinoma Benign:1
May 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
7.1
DANN
Benign
0.68
PhyloP100
-0.60
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs777359545; hg19: chr4-169799315; API